Discover a new way to find and share stories you'll love… Learn about Reading Desk

Trend Results : Cancer Center


Related Searches

Blog Post Results (1-20 of 3435)

FILTER RESULTS

Researchers Identify Genetic Variants Predicting Aggressive Prostate Cancers

Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on understanding the genetic interaction between single nucleotide polymorphisms (SNPs). Show More Summary

Vince Flynn Dead at 47

Damn. Minnesota author Vince Flynn has died after a long battle with prostate cancer. WCCO-TV has learned that Flynn died Wednesday morning at United Hospital in St. Paul. Flynn has authored 15 novels centered around the character of Mitch Rapp,...

AACI Awards Two Translational Research Fellowships

The Association of American Cancer Institutes (AACI) has awarded AACI Translational Cancer Research Fellowships to Olya Grove, PhD, and Piro Lito, MD, PhD. The scientists are from Moffitt Cancer Center, in Tampa, Florida, and Memorial Sloan-Kettering Cancer Center, in New York City, respectively.

GW Cancer Institute Publishes Overview on Value of Patient Navigation for Community Cancer Centers

A recently published paper by the George Washington University Cancer Institute addresses the value of patient navigation programs for community cancer centers.

Certain Types of Graft-Versus-Host Disease May Increase Risk of Death

Joseph Pidala, M.D., M.S., assistant member of the Blood and Bone Marrow Transplant and Immunology programs at Moffitt Cancer Center, and colleagues from the Chronic Graft-Versus-Host Disease Consortium have determined that certain gastrointestinal and liver-related types of chronic graft-versus-host disease (GVHD) are associated with worsened quality of life and death.

Growth Of Aggressive Brain Cancer Driven By Metabolic Molecule

A study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) has identified an abnormal metabolic pathway that drives cancer-cell growth in a particular glioblastoma subtype. Show More Summary

Women Receive Mammograms At Supermarket

AMARILLO, TEXAS -- Last Saturday, The Texas Tech University Health Sciences Center at Amarillo’s Breast Center For Excellence teamed up with United Supermarkets to offer free mammograms to women shoppers. Through a Cancer PreventionShow More Summary

Gilda Radner’s Cancer Center To Earn Money From Ron James Performance

Gilda’s Club Greater Toronto is about to earn some much needed money with the help of legendary comedian Ron James. Gilda’s Club is a cancer care centre named after former Saturday Night Live performer Gilda Radner. Legendary comedian Ron James will host It’s Always Something, a comedy event presented by The Keg Steakhouse & Bar. Show More Summary

Superformula against cancer: Superhero chemotherapy for child cancer patients in Brazil

5 days agoOdd : Boing Boing

Ad agency JWT Brazil created a "Superformula" to fight cancer. They worked with the A.C. Camargo Cancer Center in Brazil and another agency client, Warner Bros., to transform chemotherapy into "superformula," with hopes of changing child patients' negative perception of the treatment.

Landmark Case Opens Door to Cheaper Cancer Screnings

In a landmark case centering on gene patenting, the U.S. Supreme Court on Thursday ruled unanimously that patents can be held on synthetically produced genetic material but not on naturally occurring human genes. This will profoundly...Show More Summary

IOM Standards For Clinical Practice Not Fully Met By Cancer Guidelines

In an age when evidence-based care is increasingly important, how trustworthy are current clinical practice guidelines? Researchers at the University of Michigan Comprehensive Cancer Center looked at 169 cancer clinical practice guidelines...Show More Summary

Metabolic molecule drives growth of aggressive brain cancer

COLUMBUS, Ohio – A study led by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) has identified an abnormal metabolic pathway that drives cancer-cell growth in a particular glioblastoma subtype. Show More Summary

Northwest Biotherapeutics: Targeting Glioblastoma With Immunotherapy

By Brian L. Wilson: This morning, Northwest Biotherapeutics (NWBO) announced the initiation of a 60-patient Phase I/II trial at the MD Anderson Cancer Center for the newest version of their personalized cancer immunotherapy DCVax-Direct - here is the press release (link). Show More Summary

Monell-led research identifies scent of melanoma

PHILADELPHIA (June 13, 2013) -- According to new research from the Monell Center and collaborating institutions, odors from human skin cells can be used to identify melanoma, the deadliest form of skin cancer. In addition to detecting...Show More Summary

Northwest Bio: M.D. Anderson's Lead Role In DC Vax Direct Trial Is Encouraging

By Smith On Stocks: Northwest Biotherapeutics (NWBO) announced today that the Phase I/II trial of DCVax Direct has been initiated at M.D. Anderson Cancer Center in Houston, Texas; this is one of the premier centers for cancer drug development in the US. Show More Summary

Side Effects Of Radiation To Treat Prostate Cancer Reduced By Biodegradable Implant

Several years ago, Virginia Commonwealth University Massey Cancer Center became the first center in the United States to test an Israeli-invented device designed to increase the space between the prostate and the rectum in prostate cancer patients undergoing radiation therapy. Show More Summary

Study finds cancer guidelines do not fully meet IOM standards

ANN ARBOR, Mich. — In an age when evidence-based care is increasingly important, how trustworthy are current clinical practice guidelines? Researchers at the University of Michigan Comprehensive Cancer Center looked at 169 cancer clinical...Show More Summary

New Sickle Cell Anemia Therapy Advances to Phase II Clinical Trials

Seeking to improve the lives of sickle cell anemia sufferers around the world, researchers from the La Jolla Institute for Allergy and Immunology, the Dana-Farber/Children's Hospital Cancer Center in Boston and the BloodCenter of Wisconsin...Show More Summary

Chronic Myeloid Leukemia Patients On Kinase Inhibitors Report Serious Quality-Of-Life Issues

Researchers at Moffitt Cancer Center have determined that chronic myeloid leukemia patients who are treated with a class of oral chemotherapy drugs known as a tyrosine kinase inhibitors have significant side effects and quality-of-life issues that need to be addressed. Show More Summary

Study Finds Cancer Guidelines Do Not Fully Meet IOM Standards

Researchers at the University of Michigan Comprehensive Cancer Center looked at 169 cancer clinical practice guidelines and found that none fully met standards set in 2011 by the Institute of Medicine.

Copyright © 2011 Regator, LLC